naion and semaglutide A recent Veterans Health Administration–based target trial emulation evaluated the incidence of nonarteritic anterior ischemic optic neuropathy ( NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 Study links Wegovy to increased

There is no universal answer, and any clinician who hands you one is not serving your best interest

The polymorphic human glutathione transferase T1-1, the most efficient glutathione transferase in the denitrosation and inactivation of the anticancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea

Until human clinical trials provide definitive answers, BPC-157 remains a fascinating but incompletely understood compound with promising preclinical support

Non-coding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), are pivotal mediators of tubular pyroptosis in DKD (178, 179)

S P O N S O R E D C O N T E N T About Josh Redd Josh Redd, MS, DABFM, DAAIM, is a chiropractic physician and author of the Amazon bestselling book The Truth About Low Thyroid. Redd owns seven functional medicine clinics in the western United States and sees patients from across the country and around the world who are suffering from challenging autoimmune, endocrine and neurological disorders

It is FDA-approved, widely available, and produces roughly 30-50% more weight loss than semaglutide in clinical trials